|A prospective study of the impact of fluorodeoxyglucose positron emission tomography with concurrent non‐contrast CT scanning on the management of operable pancreatic and peri …|
ME Burge, N O'Rourke, D Cavallucci, R Bryant, A Francesconi, K Houston, ...
HPB 17 (7), 624-631, 2015
|Using a Delphi process to determine optimal care for patients with pancreatic cancer|
EA Burmeister, SJ Jordan, DL O'Connell, VL Beesley, D Goldstein, ...
Asia‐Pacific Journal of Clinical Oncology 12 (2), 105-114, 2016
|Previous Bevacizumab and Efficacy of Later Anti–Epidermal Growth Factor Receptor Antibodies in Metastatic Colorectal Cancer: Results From a Large International Registry|
M Burge, C Semira, B Lee, M Lee, S Kosmider, R Wong, J Shapiro, B Ma, ...
Clinical colorectal cancer 17 (3), e593-e599, 2018
|Metastatic colorectal cancer during pregnancy: A tertiary center experience and review of the literature|
SF Lee, M Burge, M Eastgate
Obstetric medicine 12 (1), 38-41, 2019
|Pushing the accelerator and releasing the brake: A phase I dose escalation study evaluating a LAG-3 fusion protein (eftilagimod alpha), together with pembrolizumab in …|
MA Eastgate, V Atkinson, MA Khattak, AC Roy, AM Haydon, C Mueller, ...
Journal of Clinical Oncology 36 (15_suppl), e15099-e15099, 2018
|Supporting patients and carers affected by pancreatic cancer: A feasibility study of a counselling intervention|
VL Beesley, J Turner, RJ Chan, P Yates, LG Gordon, M Burge, ...
European Journal of Oncology Nursing, 101729, 2020
|Tumor CD155 expression is associated with resistance to anti-PD1 immunotherapy in metastatic melanoma|
A Lepletier, J Madore, JS O'Donnell, RL Johnston, XY Li, E McDonald, ...
Clinical Cancer Research, 2020
|Resistance to immunotherapy is associated with high parenchymal PD1+ CD8+/CD8+ T cells (PD1tR) driven by tumour CD155|
AL de Oliveira, J Madore, JS O’donnell, RL Johnston, M Eastgate, ...
Annals of Oncology 30, xi48, 2019
|Royal Brisbane MedicalOncology Clinic Activity Review|
A Kuchel, A Kermond, J Lonton, D Wyld, M Eastgate
Asia-Pacific Journal of Clinical Oncology 15, 155-155, 2019
|Colorectal cancer patient reported outcomes: Putting theory into practice|
G Bryant, M Eastgate, D Wyld, M Burge, D Thaker, M Busato
Asia-Pacific Journal of Clinical Oncology 14, 107-108, 2018
|Dietary patterns and attitudes in cancer patients.|
SF Lee, D Wyld, T Brown, MA Eastgate
Journal of Clinical Oncology 36 (15_suppl), e22055-e22055, 2018
|Dietary patterns and attitudes in cancer survivors|
SF Lee, D Wyld, M Eastgate, T Brown
|Catheter-Associated Bloodstream Infections (CA-BSI) in Adults with Cancer: A Prospective Randomized Controlled Trial|
P Mollee, S Okano, D Looke, G Kennedy, J Harper, J Clouston, ...
Blood 130 (Supplement 1), 4729-4729, 2017
|Pushing the accelerator and releasing the brake: testing the soluble LAG-3 protein (IMP321), an antigen presenting cell activator, together with pembrolizumab in unresectable …|
V Atkinson, A Haydon, M Eastgate, A Roy, A Khattak, C Mueller, ...
JOURNAL FOR IMMUNOTHERAPY OF CANCER 5, 2017
|Evaluation of Medical Oncology Patients Admitted with Fever|
KH You, B Gunawan, M Eastgate, D Wyld
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY 13, 76-76, 2017
|Single institution review of the correlation between the clinical and histopathological staging in newly diagnosed rectal cancer patients in 2015|
P Thanayankeezhil, D Wyld, M Burge, M Eastgate
|Outcomes comparing right and left-sided metastatic colorectal cancer: A multi-centre retrospective analysis in Queensland, Australia|
M Allen, S Conroy, M Eastgate, D Wyld, V Whitehall, M Burge
|Exploring attitudes and barriers to research in medical oncology training|
R Ladwa, M Eastgate
Asia-Pacific Journal of Clinical Oncology 13, 61-61, 2017
|Characterising Acute Ward Admissions of Advanced Cancer Patients to the Royal Brisbane Hospital|
D Mittal, M Eustace, M Eastgate, M Burge, D Wyld
Asia-Pacific Journal of Clinical Oncology 13, 132-132, 2017
|Lean thinking: Exploring the volume of overhead and supplementary tasks (OST) in cancer care (CC) in the oncology outpatient encounter (OOE) in two tertiary centres.|
GD Peters, M Rasool, DD Smith, R Ladwa, D Wyld, MA Eastgate, W Xu, ...
Journal of Clinical Oncology 34 (15_suppl), 6589-6589, 2016